{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T13:22:22Z","timestamp":1775395342063,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[1998,4,30]],"date-time":"1998-04-30T00:00:00Z","timestamp":893894400000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1016\/s0264-410x(97)00238-7","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T21:18:44Z","timestamp":1027631924000},"page":"590-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein"],"prefix":"10.1016","volume":"16","author":[{"given":"E.H.","family":"Nardin","sequence":"first","affiliation":[]},{"given":"J.M.","family":"Calvo-Calle","sequence":"additional","affiliation":[]},{"given":"G.A.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"P.","family":"Clavijo","sequence":"additional","affiliation":[]},{"given":"R.","family":"Nussenzweig","sequence":"additional","affiliation":[]},{"given":"R.","family":"Simon","sequence":"additional","affiliation":[]},{"given":"W.","family":"Zeng","sequence":"additional","affiliation":[]},{"given":"K.","family":"Rose","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0264-410X(97)00238-7_BIB1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(92)90251-7","article-title":"The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites","volume":"70","author":"Cerami","year":"1992","journal-title":"Cell"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0065-2776(08)60695-1","article-title":"Rationale for the development of an engineered sporozoite malaria vaccine","volume":"45","author":"Nussenzweig","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.iy.11.040193.003351","article-title":"T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages","volume":"11","author":"Nardin","year":"1993","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria","volume":"336","author":"Stoute","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/328257a0","article-title":"Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites","volume":"328","author":"Herrington","year":"1987","journal-title":"Nature"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4049\/jimmunol.140.2.626","article-title":"Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite Plasmodium falciparum","volume":"140","author":"Etlinger","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB7","first-page":"5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.171.1.299","article-title":"Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria","volume":"171","author":"Tam","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-2478(90)90126-B","article-title":"Protective anti-sporozoite antibodies induced by chemically defined synthetic vaccine","volume":"25","author":"Zavala","year":"1990","journal-title":"Immunol. Lett."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB10","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.4049\/jimmunol.154.6.2784","article-title":"Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine","volume":"154","author":"Wang","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB11","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/eji.1830211217","article-title":"Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein","volume":"21","author":"Munesinghe","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4049\/jimmunol.150.4.1403","article-title":"Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum","volume":"150","author":"Calvo-Calle","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0264-410X(94)90337-9","article-title":"Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the P. falciparum CS protein: possible vaccine application","volume":"12","author":"de Oliveira","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.164.2.655","article-title":"Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to a single malaria T epitope in highly repetitive vaccine","volume":"164","author":"Good","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB15","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.4049\/jimmunol.137.9.2952","article-title":"The antibody response in mice to carrier free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab restricted: possible implications for malaria vaccines","volume":"137","author":"Del Guidice","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.159.3.1362","article-title":"Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of a universal T cell epitope in the P. falciparum CS protein","volume":"159","author":"Calvo-Calle","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB17","first-page":"1199","article-title":"Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule","volume":"85","author":"Good","year":"1988"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/intimm\/3.10.997","article-title":"Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the P. falciparum CS protein","volume":"3","author":"Moreno","year":"1991","journal-title":"Int. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.151.1.489","article-title":"CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein","volume":"151","author":"Moreno","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1021\/ja00080a004","article-title":"Facile synthesis of homogeneous artificial proteins","volume":"116","author":"Rose","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0161-5890(95)00090-9","article-title":"A synthetic peptide-based polyoxime vaccine construct of high purity and activity","volume":"32","author":"Rose","year":"1995","journal-title":"Mol. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/psc.51","article-title":"Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry","volume":"2","author":"Zeng","year":"1996","journal-title":"J. Peptide Sci."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/bc960039m","article-title":"Natural peptides as building blocks for the synthesis of large protein-like molecules with hydrazone and oxime linkages","volume":"7","author":"Rose","year":"1996","journal-title":"Bioconj. Chem."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.156.1.20","article-title":"Circumsporozoite proteins of human malaria parasites Plasmodium vivax and Plasmodium falciparum","volume":"156","author":"Nardin","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2409595","article-title":"Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria","volume":"228","author":"Zavala","year":"1985","journal-title":"Science"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB26","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.2480642","article-title":"Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer","volume":"246","author":"Nardin","year":"1989","journal-title":"Science"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB27","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.4049\/jimmunol.154.8.3922","article-title":"Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum","volume":"154","author":"Blum-Tirouvanziam","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB28","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4049\/jimmunol.137.8.2676","article-title":"A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide constitutes a potent immune adjuvant","volume":"137","author":"Lex","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB29","first-page":"3879","article-title":"Macromolecular assemblage in the design of a synthetic AIDS vaccine","volume":"89","author":"Defoort","year":"1992"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-3011.1992.tb00294.x","article-title":"A rational design of synthetic peptide vaccine with a built in adjuvant: a modular approach for unambiguity","volume":"40","author":"Defoort","year":"1992","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1399-3011.1992.tb00291.x","article-title":"In situ neutralization in Boc-chemistry solid phase peptide synthesis: rapid, high yield assembly of difficult sequences","volume":"40","author":"Schnolzer","year":"1992","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB32","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/eji.1830200733","article-title":"A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes","volume":"20","author":"Del Giudice","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0264-410X(89)90007-8","article-title":"Novel low molecular weight synthetic vaccine against foot-and-mouth disease containing a potent B cell and macrophage activator","volume":"7","author":"Wiesmuller","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB34","first-page":"109","article-title":"The antibody response in Balbc mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant","volume":"72","author":"Wiesmuller","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/342561a0","article-title":"in vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine","volume":"342","author":"Deres","year":"1989","journal-title":"Nature"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB36","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.4049\/jimmunol.148.6.1871","article-title":"Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule","volume":"148","author":"Romero","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.159.3.1383","article-title":"The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection","volume":"159","author":"Livingston","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB38","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.1827210","article-title":"Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein","volume":"252","author":"Khusmith","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0264-410X(97)00238-7_BIB39","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/iai.62.7.2979-2983.1994","article-title":"Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T cell clone recognizing sporozoite surface protein 2","volume":"62","author":"Khusmith","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/expr.1995.1054","article-title":"Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody","volume":"80","author":"Charoenvit","year":"1995","journal-title":"Exp. Parasitol."},{"key":"10.1016\/S0264-410X(97)00238-7_BIB41","doi-asserted-by":"crossref","first-page":"17861","DOI":"10.1074\/jbc.271.30.17861","article-title":"Identification and characterization of the protective hepatocyte erythrocyte protein 17kDa gene of Plasmodium yoelii homolog of Plasmodium falciparum exported protein 1","volume":"271","author":"Doolan","year":"1996","journal-title":"J. Biol. Chem."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X97002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X97002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:12:15Z","timestamp":1759399935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X97002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["S0264410X97002387"],"URL":"https:\/\/doi.org\/10.1016\/s0264-410x(97)00238-7","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0264-410X(97)00238-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}